Overview

This trial is active, not recruiting.

Condition coronary artery disease
Treatment observational study, no intervention.
Sponsor UMC Utrecht
Start date October 2011
End date December 2014
Trial size 3000 participants
Trial identifier NCT02304744, 11/183

Summary

UCORBIO enrolls patients who undergo coronary angiography (for any indication). The investigators draw blood at the moment of insertion of the procedural arterial catheter.

At the moment of inclusion indication, procedural details, risk factor status, medication use and quality of life (RAND-36 and EuroQoL) is assessed. Patients are then followed-up for the occurrence of major adverse cardiovascular events for 5 years. During the follow-up period patients receive a questionnaire every year to check for hospital admissions. The questionnaires at two and five years of follow-up are enriched with quality of life questionnaires (RAND-36 and EuroQoL).

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Measure
major adverse cardiovascular events [MACE] (Stroke, myocardial infarction, coronary revascularization, death)
time frame: 5 years

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Coronary angiography Exclusion Criteria: - Age < 18 years.

Additional Information

Official title Utrecht Coronary Biobank (UCORBIO)
Trial information was received from ClinicalTrials.gov and was last updated in March 2015.
Information provided to ClinicalTrials.gov by UMC Utrecht.